Support psychedelic science: research that needs you

1. Maastricht University - Open the survey.

We are researchers at Maastricht University preparing a series of trials using novel psychedelic drugs such as 2C-B.

As the scientific literature is lacking at this time, we are looking for volunteers from the novel psychedelic-using community to provide us with information about their personal experience with these substances, including dose, and negative and positive effects.

Your contribution would assist in developing our understanding of these substances as to better guide harm-reduction efforts while helping to identify potential therapeutic applications.

We are currently collecting anonymised data and will be making our results available to the general and scientific community through academic journals. You can find an example of one of our previous studies at https://doi.org/10.1177/0091450919863899.

Reach out for questions at:

2. Charité Berlin - Open the survey.

The Corona Drug Survey is conducted by the Psychotropic Substances Group of Charité – Universitätsmedizin Berlin.

The aim of the study is to determine how the consumption of psychoactive substances has changed as a result of the COVID-19 pandemic (“corona crisis”).

We investigate how the current situation affects the subjective experience and use of psychoactive substances. We also want to find out whether there are differences between substances.

Reach out for questions at:

3. GDS: Corona Survey - Open the survey.

This survey is conducted by the Global Drug Survey team.

We want to better understand how COVID-19 is affecting your daily life, your relationships, your mental health and wellbeing, as well as your use of alcohol and other drugs.

Participation in the survey will take about 15 minutes if you only drink alcohol, and another 10 minutes if you use other drugs.

At the end, you can indicate if you are interested in joining a longitudinal study that will track people’s alcohol and other drug use patterns over time.

Reach out for questions at: